Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of (Deficit) Equity

v3.22.2
Condensed Consolidated Statements of (Deficit) Equity - USD ($)
$ in Thousands
Total
Total Stockholders’ (Deficit) Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Series B Preferred Stock
Total Stockholders’ (Deficit) Equity
Series B Preferred Stock
Preferred Stock
Beginning balance (in shares) at Dec. 31, 2020     9,703,874     224,429 562     1,875,748
Beginning balance at Dec. 31, 2020 $ 16,849 $ 14,918 $ 97 $ 234,061 $ (260,867) $ 1,931 $ 453     $ 41,174
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount               $ 22 $ 22 $ 22
Conversion of Operating Partnership units to Common Stock (in shares)     2,864     (2,864)        
Conversion of Operating Partnership units to Common Stock 0 9   9   $ (9)        
Adjustment for noncontrolling interest in operating partnership 0 16   16   (16)        
Dividends and distributions (2,273) (2,273)     (2,273)          
Deemed contribution related to preferred stock redemption 4,389 4,389     4,389          
Net (Loss) Income (4,034) (4,049)     (4,049) $ 15        
Ending balance (in shares) at Mar. 31, 2021     9,706,738     221,565 562     1,875,748
Ending balance at Mar. 31, 2021 14,953 13,032 $ 97 234,086 (262,800) $ 1,921 $ 453     $ 41,196
Beginning balance (in shares) at Dec. 31, 2020     9,703,874     224,429 562     1,875,748
Beginning balance at Dec. 31, 2020 16,849 14,918 $ 97 234,061 (260,867) $ 1,931 $ 453     $ 41,174
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 309                  
Deemed contribution related to preferred stock redemption 5,040                  
Net (Loss) Income (7,101)                  
Ending balance (in shares) at Jun. 30, 2021     9,710,414     217,889 562     1,875,748
Ending balance at Jun. 30, 2021 10,370 8,482 $ 97 234,119 (267,405) $ 1,888 $ 453     $ 41,218
Beginning balance (in shares) at Mar. 31, 2021     9,706,738     221,565 562     1,875,748
Beginning balance at Mar. 31, 2021 14,953 13,032 $ 97 234,086 (262,800) $ 1,921 $ 453     $ 41,196
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 22 22               $ 22
Conversion of Operating Partnership units to Common Stock (in shares)     3,676     (3,676)        
Conversion of Operating Partnership units to Common Stock 0 18   18   $ (18)        
Adjustment for noncontrolling interest in operating partnership 0 15   15   $ (15)        
Dividends and distributions (2,189) (2,189)     (2,189)          
Deemed contribution related to preferred stock redemption 651 651     651          
Net (Loss) Income (3,067) (3,067)     (3,067)          
Ending balance (in shares) at Jun. 30, 2021     9,710,414     217,889 562     1,875,748
Ending balance at Jun. 30, 2021 10,370 8,482 $ 97 234,119 (267,405) $ 1,888 $ 453     $ 41,218
Beginning balance (in shares) at Dec. 31, 2021     9,720,532     215,343 562     1,872,448
Beginning balance at Dec. 31, 2021 3,802 1,861 $ 97 234,229 (274,107) $ 1,941 $ 453     $ 41,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 22 22               $ 22
Conversion of Series B Preferred Stock to Common Stock (in shares)     2,561             (4,105)
Conversion of Series B Preferred Stock to Common Stock 0     90           $ (90)
Dividends and distributions (2,264) (2,264)     (2,264)          
Net (Loss) Income (4,576) (4,580)     (4,580) $ 4        
Ending balance (in shares) at Mar. 31, 2022     9,723,093     215,343 562     1,868,343
Ending balance at Mar. 31, 2022 (3,016) (4,961) $ 97 234,319 (280,951) $ 1,945 $ 453     $ 41,121
Beginning balance (in shares) at Dec. 31, 2021     9,720,532     215,343 562     1,872,448
Beginning balance at Dec. 31, 2021 3,802 1,861 $ 97 234,229 (274,107) $ 1,941 $ 453     $ 41,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 292                  
Deemed contribution related to preferred stock redemption 0                  
Net (Loss) Income (4,629)                  
Ending balance (in shares) at Jun. 30, 2022     9,792,713     145,723 562     2,301,337
Ending balance at Jun. 30, 2022 (3,212) (4,527) $ 98 234,947 (283,267) $ 1,315 $ 453     $ 43,242
Beginning balance (in shares) at Mar. 31, 2022     9,723,093     215,343 562     1,868,343
Beginning balance at Mar. 31, 2022 (3,016) (4,961) $ 97 234,319 (280,951) $ 1,945 $ 453     $ 41,121
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount   22           $ 22   $ 22
Conversion of Operating Partnership units to Common Stock (in shares)     69,620     (69,620)        
Conversion of Operating Partnership units to Common Stock 0 159 $ 1 158   $ (159)        
Adjustment for noncontrolling interest in operating partnership 0 470   470   (470)        
Paid-in-kind interest, issuance of Series B Preferred Stock (in shares)                   432,994
Paid-in-kind interest, issuance of Series B Preferred Stock 2,099 2,099               $ 2,099
Dividends and distributions (2,264) (2,264)     (2,264)          
Deemed contribution related to preferred stock redemption 0                  
Net (Loss) Income (53) (52)     (52) $ (1)        
Ending balance (in shares) at Jun. 30, 2022     9,792,713     145,723 562     2,301,337
Ending balance at Jun. 30, 2022 $ (3,212) $ (4,527) $ 98 $ 234,947 $ (283,267) $ 1,315 $ 453     $ 43,242